Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase (MTHFR) deficient mice

Frontiers in Aging Neuroscience

Volumn 6, Issue AUG, 2014, Pages

  Sontag, Jean Marie ^a   Wasek, Brandi ^b   Taleski, Goce ^a   Smith, Josephine ^a   Arning, Erland ^b   Sontag, Estelle ^a   Bottiglieri, Teodoro ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Folate; LCMT1; Methylation; MTHFR; PP2A; Tau phosphorylation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CALCINEURIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN CARBOXYL METHYLTRANSFERASE; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DOWN REGULATION; FOLIC ACID DEFICIENCY; HIPPOCAMPUS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION;

EID: 84906265016     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00214     Document Type: Article

References (55)

1. Bottiglieri, T., Arning, E., Wasek, B., Nunbhakdi-Craig, V., Sontag, J.M., and Sontag, E. (2012). Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain. J Neurosci 32, 9173-9181.
2. Bottiglieri, T., Reynolds, E.H., and Laundy, M. (2000). Folate in CSF and age. Journal of neurology, neurosurgery, and psychiatry 69, 562.
3. Botto, L.D., and Yang, Q. (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. American journal of epidemiology 151, 862-877.
4. Chen, Z., Karaplis, A.C., Ackerman, S.L., Pogribny, I.P., Melnyk, S., Lussier-Cacan, S., Chen, M.F., Pai, A., John, S.W., Smith, R.S., Bottiglieri, T., Bagley, P., Selhub, J., Rudnicki, M.A., James, S.J., and Rozen, R. (2001). Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Human molecular genetics 10, 433-443.
5. Chen, Z., Schwahn, B.C., Wu, Q., He, X., and Rozen, R. (2005). Postnatal cerebellar defects in mice deficient in methylenetetrahydrofolate reductase. International journal of developmental neuroscience: the official journal of the International Society for Developmental Neuroscience 23, 465-474.
6. Coppede, F., Tannorella, P., Pezzini, I., Migheli, F., Ricci, G., Caldarazzo Lenco, E., Piaceri, I., Polini, A., Nacmias, B., Monzani, F., Sorbi, S., Siciliano, G., and Migliore, L. (2012). Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's disease patients and healthy controls. Antioxidants & redox signaling 17, 195-204.
7. De Baere, I., Derua, R., Janssens, V., Van Hoof, C., Waelkens, E., Merlevede, W., and Goris, J. (1999). Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue. Biochemistry 38, 16539-16547.
8. Fowler, B. (2005). Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Seminars in vascular medicine 5, 77-86.
9. Ghandour, H., Chen, Z., Selhub, J., and Rozen, R. (2004). Mice deficient in methylenetetrahydrofolate reductase exhibit tissue-specific distribution of folates. The Journal of nutrition 134, 2975-2978.
10. Gilbody, S., Lewis, S., and Lightfoot, T. (2007). Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. American journal of epidemiology 165, 1-13.
11. Goyette, P., Christensen, B., Rosenblatt, D.S., and Rozen, R. (1996). Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. American journal of human genetics 59, 1268-1275.
12. Grapp, M., Just, I.A., Linnankivi, T., Wolf, P., Lucke, T., Hausler, M., Gartner, J., and Steinfeld, R. (2012). Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain 135, 2022-2031.
13. Greenberg, S.G., Davies, P., Schein, J.D., and Binder, L.I. (1992). Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267, 564-569.
14. Herrmann, W., and Obeid, R. (2007). Biomarkers of folate and vitamin B(12) status in cerebrospinal fluid. Clinical chemistry and laboratory medicine: CCLM / FESCC 45, 1614-1620.
15. Hobbs, C.A., Sherman, S.L., Yi, P., Hopkins, S.E., Torfs, C.P., Hine, R.J., Pogribna, M., Rozen, R., and James, S.J. (2000). Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. American journal of human genetics 67, 623-630.
16. Hua, Y., Zhao, H., Kong, Y., and Ye, M. (2011). Association between the MTHFR gene and Alzheimer's disease: a meta-analysis. The International journal of neuroscience 121, 462-471.
17. Jadavji, N.M., Deng, L., Leclerc, D., Malysheva, O., Bedell, B.J., Caudill, M.A., and Rozen, R. (2012). Severe methylenetetrahydrofolate reductase deficiency in mice results in behavioral anomalies with morphological and biochemical changes in hippocampus. Molecular genetics and metabolism 106, 149-159.
18. Kageyama, M., Hiraoka, M., and Kagawa, Y. (2008). Relationship between genetic polymorphism, serum folate and homocysteine in Alzheimer's disease. Asia-Pacific journal of public health / Asia-Pacific Academic Consortium for Public Health 20 Suppl, 111-117.
19. Kuszczyk, M., Gordon-Krajcer, W., and Lazarewicz, J.W. (2009). Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A mediated dephosphorylation of tau. Neurochemistry international 55, 174-180.
20. Lawrance, A.K., Racine, J., Deng, L., Wang, X., Lachapelle, P., and Rozen, R. (2011). Complete deficiency of methylenetetrahydrofolate reductase in mice is associated with impaired retinal function and variable mortality, hematological profiles, and reproductive outcomes. Journal of inherited metabolic disease 34, 147-157.
21. Leclerc, D., and Rozen, R. (2007). [Molecular genetics of MTHFR: polymorphisms are not all benign]. Medecine sciences: M/S 23, 297-302.
22. Lee, J., Chen, Y., Tolstykh, T., and Stock, J. (1996). A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. Proceedings of the National Academy of Sciences of the United States of America 93, 6043-6047.
23. Lee, J.A., and Pallas, D.C. (2007). Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells. The Journal of biological chemistry 282, 30974-30984.
24. Leulliot, N., Quevillon-Cheruel, S., Sorel, I., Li De La Sierra-Gallay, I., Collinet, B., Graille, M., Blondeau, K., Bettache, N., Poupon, A., Janin, J., and Van Tilbeurgh, H. (2004). Structure of protein phosphatase methyltransferase 1 (PPM1), a leucine carboxyl methyltransferase involved in the regulation of protein phosphatase 2A activity. The Journal of biological chemistry 279, 8351-8358.
25. Liao, D., Miller, E.C., and Teravskis, P.J. (2014). Tau acts as a mediator for Alzheimer's disease-related synaptic deficits. The European journal of neuroscience 39, 1202-1213.
26. Liu, R., Geng, P., Ma, M., Yu, S., Yang, M., He, M., Dong, Z., and Zhang, W. (2014). MTHFR C677T polymorphism and migraine risk: a meta-analysis. Journal of the neurological sciences 336, 68-73.
27. Lopes Da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K., Sijben, J., Groenendijk, M., and Stijnen, T. (2013). Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis. Alzheimer's & dementia: the journal of the Alzheimer's Association.
28. Mackay, K.B., Tu, Y., Young, S.G., Clarke, S.G. (2013). Circumventing embryonic lethality with Lcmt1 deficiency: generation of hypomorphic Lcmt1 mice with reduced protein phosphatase 2A methyltransferase expression and defects in insulin signaling. PloS one 8, e65967.
29. Mansouri, L., Fekih-Mrissa, N., Klai, S., Mansour, M., Gritli, N., and Mrissa, R. (2013). Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer's disease. Clinical neurology and neurosurgery 115, 1693-1696.
30. Mcnulty, H., Strain, J.J., Pentieva, K., and Ward, M. (2012). C(1) metabolism and CVD outcomes in older adults. The Proceedings of the Nutrition Society 71, 213-221.
31. Morris, M.S. (2012). The role of B vitamins in preventing and treating cognitive impairment and decline. Advances in nutrition 3, 801-812.
32. Nazki, F.H., Sameer, A.S., and Ganaie, B.A. (2014). Folate: metabolism, genes, polymorphisms and the associated diseases. Gene 533, 11-20.
33. Nelson, B.C., Pfeiffer, C.M., Margolis, S.A., and Nelson, C.P. (2004). Solid-phase extraction-electrospray ionization mass spectrometry for the quantification of folate in human plasma or serum. Analytical biochemistry 325, 41-51.
34. Papon, M.A., El Khoury, N.B., Marcouiller, F., Julien, C., Morin, F., Bretteville, A., Petry, F.R., Gaudreau, S., Amrani, A., Mathews, P.M., Hebert, S.S., and Planel, E. (2013). Deregulation of protein phosphatase 2A and hyperphosphorylation of tau protein following onset of diabetes in NOD mice. Diabetes 62, 609-617.
35. Rozen, R. (1997). Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thrombosis and haemostasis 78, 523-526.
36. Rozen, R. (2000). Genetic modulation of homocysteinemia. Seminars in thrombosis and hemostasis 26, 255-261.
37. Schwahn, B., and Rozen, R. (2001). Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. American journal of pharmacogenomics: genomics-related research in drug development and clinical practice 1, 189-201.
38. Sontag, E., Hladik, C., Montgomery, L., Luangpirom, A., Mudrak, I., Ogris, E., and White, C.L., 3rd (2004a). Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol 63, 1080-1091.
39. Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., and White, C.L., 3rd (2004b). Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63, 287-301.
40. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G.S., and Mumby, M.C. (1996). Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17, 1201-1207.
41. Sontag, E., Nunbhakdi-Craig, V., Sontag, J.M., Diaz-Arrastia, R., Ogris, E., Dayal, S., Lentz, S.R., Arning, E., and Bottiglieri, T. (2007). Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J Neurosci 27, 2751-2759.
42. Sontag, J.M., Nunbhakdi-Craig, V., Montgomery, L., Arning, E., Bottiglieri, T., and Sontag, E. (2008). Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation. J Neurosci 28, 11477-11487.
43. Sontag, J.M., and Sontag, E. (2014). Protein phosphatase 2A dysfunction in Alzheimer's disease. Frontiers in Molecular Neuroscience 7, 16.
44. Stanevich, V., Jiang, L., Satyshur, K.A., Li, Y., Jeffrey, P.D., Li, Z., Menden, P., Semmelhack, M.F., and Xing, Y. (2011). The structural basis for tight control of PP2A methylation and function by LCMT-1. Molecular cell 41, 331-342.
45. Tsai, M.L., Cronin, N., and Djordjevic, S. (2011). The structure of human leucine carboxyl methyltransferase 1 that regulates protein phosphatase PP2A. Acta crystallographica. Section D, Biological crystallography 67, 14-24.
46. Wang, B., Jin, F., Kan, R., Ji, S., Zhang, C., Lu, Z., Zheng, C., Yang, Z., and Wang, L. (2005). Association of MTHFR gene polymorphism C677T with susceptibility to late onset Alzheimer's disease. Journal of molecular neuroscience: MN 27, 23-27.
47. Wang, J.Z., Xia, Y.Y., Grundke-Iqbal, I., and Iqbal, K. (2013). Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. Journal of Alzheimer's disease: JAD 33 Suppl 1, S123-139.
48. Wang, S.C., Oelze, B., and Schumacher, A. (2008). Age-specific epigenetic drift in late-onset Alzheimer's disease. PloS one 3, e2698.
49. Watkins, D., and Rosenblatt, D.S. (2012). Update and new concepts in vitamin responsive disorders of folate transport and metabolism. Journal of inherited metabolic disease 35, 665-670.
50. Wu, Y.L., Ding, X.X., Sun, Y.H., Yang, H.Y., and Sun, L. (2013). Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. Journal of the neurological sciences 335, 14-21.
51. Wu, Y.L., Yang, H.Y., Ding, X.X., Zhao, X., Chen, J., Bi, P., and Sun, Y.H. (2014). Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: A meta-analysis. Seizure: the journal of the British Epilepsy Association.
52. Xu, Y., Chen, Y., Zhang, P., Jeffrey, P.D., and Shi, Y. (2008). Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Molecular cell 31, 873-885.
53. Yoon, S.Y., Choi, H.I., Choi, J.E., Sul, C.A., Choi, J.M., and Kim, D.H. (2007). Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron. Biochemical and biophysical research communications 363, 811-816.
54. Zappacosta, B., Graziano, M., Persichilli, S., Di Castelnuovo, A., Mastroiacovo, P., and Iacoviello, L. (2014). 5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults. Cell biochemistry and function 32, 1-4.
55. Zhuo, J.M., Wang, H., and Pratico, D. (2011). Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends in pharmacological sciences 32, 562-571.